cross-posted from: https://lemm.ee/post/64477597
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
cross-posted from: https://lemm.ee/post/64477597
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
Love too have my bio data for sale on the advertising market because my family members are obsessed with their pedigrees like they’re a breed of dog
What do you mean, you did not vounteered to recive the Calipers Corporation newsletter?